Artelo Biosciences annual total debt
2020
2021
2021
2022
2023
2024
2025
Artelo Biosciences Total Debt Growth & History (ARTL)
Artelo Biosciences's total debt was $506,000 for fiscal 2025.
View full Artelo Biosciences company overviewArtelo Biosciences annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $506,000 | $402,000 | +386.54% |
| 2024 | 2024-12-31 | $104,000 | $104,000 | — |
| 2023 | 2023-12-31 | $0 | −$23,000 | — |
| 2022 | 2022-12-31 | $23,000 | −$34,000 | −59.65% |
| 2021 · Dec 31 | 2021-12-31 | $57,000 | — | — |
| 2021 · Aug 31 | 2021-08-31 | $67,000 | $67,000 | — |
| 2020 | 2020-08-31 | $0 | — | — |
Artelo Biosciences quarterly total debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $49,000 | −$38,000 | −43.68% |
| Q1 2026 | 2026-03-31 | $529,000 | $434,000 | +456.84% |
| Q4 2025 | 2025-12-31 | $506,000 | $402,000 | +386.54% |
| Q3 2025 | 2025-09-30 | $954,000 | $842,000 | +751.79% |
| Q2 2025 | 2025-06-30 | $87,000 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $95,000 | −$1,000 | −1.04% |
| Q4 2024 | 2024-12-31 | $104,000 | $104,000 | — |
| Q3 2024 | 2024-09-30 | $112,000 | $112,000 | — |
| Q2 2024 | 2024-06-30 | $87,000 | $81,000 | +1350.00% |
| Q1 2024 | 2024-03-31 | $96,000 | $44,000 | +84.62% |
| Q4 2023 | 2023-12-31 | $0 | −$23,000 | — |
| Q3 2023 | 2023-09-30 | $0 | −$74,000 | — |
| Q2 2023 | 2023-06-30 | $6,000 | −$34,000 | −85.00% |
| Q1 2023 | 2023-03-31 | $52,000 | $3,000 | +6.12% |
| Q4 2022 | 2022-12-31 | $23,000 | −$34,000 | −59.65% |
| Q3 2022 | 2022-09-30 | $74,000 | — | — |
| Q2 2022 | 2022-06-30 | $40,000 | — | — |
| Q1 2022 · Mar 31 | 2022-03-31 | $49,000 | — | — |
| Q4 2021 · Dec 31 | 2021-12-31 | $57,000 | — | — |
| Q1 2022 · Nov 30 | 2021-11-30 | $59,000 | $59,000 | — |
| Q4 2021 · Aug 31 | 2021-08-31 | $67,000 | $67,000 | — |
| Q3 2021 | 2021-05-31 | $0 | — | — |
| Q2 2021 | 2021-02-28 | $0 | — | — |
| Q1 2021 | 2020-11-30 | $0 | — | — |
| Q4 2020 | 2020-08-31 | $0 | — | — |
Artelo Biosciences total debt trends
Between the periods ended 2020-08-31 and 2025-12-31, Artelo Biosciences's total debt increased from $0 to $506,000, a change of $506,000. The latest reported quarter, Q2 2026, shows $49,000.
About the metric
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
Calculation and source
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artelo Biosciences source filings ↗